Comparison of the efficacy of cryopreserved human platelet lysate and refrigerated lyophilized human platelet lysate for wound healing.

Cryopreservation Gelatin hydrogel Long-term preservation Lyophilization Platelet lysate Wound healing

Journal

Regenerative therapy
ISSN: 2352-3204
Titre abrégé: Regen Ther
Pays: Netherlands
ID NLM: 101709085

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 31 08 2018
revised: 08 10 2018
accepted: 23 10 2018
entrez: 8 12 2018
pubmed: 14 12 2018
medline: 14 12 2018
Statut: epublish

Résumé

Human platelet lysate (hPL) part of the growth factor cocktail derived from human platelets, which has been applied as a cell growth supplement. The production process is easier in comparison to platelet-rich plasma; thus, hPL is now considered for use in wound healing therapy. However, methods for preserving hPL for more than several months that maintain its bioactivity must be considered, especially for chronic wound treatment. The present study compared the effects of preservation for 9 months using a refrigerator or deep freezer. We investigated three preservation conditions. In the C-hPL group, hPL was stored at -80 °C in a deep freezer for 9 months; in the CL-hPL group, hPL was cryopreserved for 9 months at -80 °C in a deep freezer then lyophilized; in the L-hPL group, lyophilized hPL was refrigerated at 4 °C for 9 months. The quantity and quality of growth factors in these three groups were measured by an ELISA and in fibroblast cell cultures. Then, gelatin hydrogel discs were impregnated with hPL and its effects with regard to the promotion of wound healing in mice were evaluated by histologic examinations. The PDGF-BB concentration in C-hPL, CL-hPL and L-hPL was 18,363 ± 370 pg/ml, 11,325 ± 171 pg/ml, and 12,307 ± 348 pg/ml, respectively; the VEGF concentration was 655 ± 23 pg/ml, 454 ± 27 pg/ml, and 499 ± 23 pg/ml, respectively; and the TGF-β1 concentration was 97,363 ± 5418 pg/ml, 73,198 ± 2442 pg/ml, and 78,034 ± 3885 pg/ml, respectively. In cell culture medium, fibroblast cell cultures were better supported in the hPL groups than in the fetal bovine serum group. In the histologic examination of the wound healing process, no differences were observed among the three preserved hPL groups with regard to epithelialization, or granulation tissue or capillary formation. The wounds in all groups had almost healed by day 14. The stability of growth factors contained in lyophilized hPL is maintained at 4 °C for up to 9 months. This was a versatile preservation method that can be applied in clinical practice.

Identifiants

pubmed: 30525065
doi: 10.1016/j.reth.2018.10.003
pii: S2352-3204(18)30044-0
pmc: PMC6260428
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1-9

Références

Wound Repair Regen. 2006 Sep-Oct;14(5):573-80
pubmed: 17014669
Transfusion. 2017 Apr;57(4):1058-1065
pubmed: 28182293
PLoS One. 2013 Jul 11;8(7):e68984
pubmed: 23874839
Plast Reconstr Surg. 2008 Nov;122(5):1352-1360
pubmed: 18971718
Tissue Eng Part A. 2013 Jun;19(11-12):1398-405
pubmed: 23427847
J Surg Res. 2019 Feb;234:190-201
pubmed: 30527473
Tissue Eng. 2005 Jul-Aug;11(7-8):1224-33
pubmed: 16144458
J Cell Mol Med. 2009 Aug;13(8B):2030-2038
pubmed: 19267882
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):307-26
pubmed: 11259845
J Artif Organs. 2015 Mar;18(1):64-71
pubmed: 25326193
J Artif Organs. 2016 Dec;19(4):372-377
pubmed: 27389012
Stem Cell Res Ther. 2018 Apr 16;9(1):107
pubmed: 29661222
World J Stem Cells. 2016 Feb 26;8(2):47-55
pubmed: 26981170
Med Mol Morphol. 2014 Jun;47(2):83-9
pubmed: 23604952
Tissue Eng. 1999 Apr;5(2):127-38
pubmed: 10358220
Sci Rep. 2016 May 04;6:25326
pubmed: 27141997
Eplasty. 2016 Aug 05;16:e22
pubmed: 27555889
Acta Biomater. 2012 May;8(5):1792-801
pubmed: 22293581
PLoS One. 2013 Dec 27;8(12):e84753
pubmed: 24386412
Platelets. 2014;25(3):211-20
pubmed: 23885791
Wound Repair Regen. 2004 Jul-Aug;12(4):485-92
pubmed: 15260814
Adv Drug Deliv Rev. 1998 May 4;31(3):287-301
pubmed: 10837630
J Dairy Sci. 2012 May;95(5):2319-25
pubmed: 22541460
J Biomater Sci Polym Ed. 2001;12(1):77-88
pubmed: 11334191

Auteurs

Sharon Claudia Notodihardjo (SC)

Department of Plastic and Reconstructive Surgery, Kansai Medical University, 2-5-1 Shin-machi, Hirakata City, Osaka, 573-1010, Japan.

Naoki Morimoto (N)

Department of Plastic and Reconstructive Surgery, Kansai Medical University, 2-5-1 Shin-machi, Hirakata City, Osaka, 573-1010, Japan.

Natsuko Kakudo (N)

Department of Plastic and Reconstructive Surgery, Kansai Medical University, 2-5-1 Shin-machi, Hirakata City, Osaka, 573-1010, Japan.

Toshihito Mitsui (T)

Department of Plastic and Reconstructive Surgery, Kansai Medical University, 2-5-1 Shin-machi, Hirakata City, Osaka, 573-1010, Japan.

Tien Minh Le (TM)

Department of Plastic and Reconstructive Surgery, Kansai Medical University, 2-5-1 Shin-machi, Hirakata City, Osaka, 573-1010, Japan.

Yasuhiko Tabata (Y)

Laboratory of Biomaterials, Department of Regeneration Science and Engineering, Institute for Frontier Life and Medical Sciences, Kyoto University, 53 Kawahara-cho Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Kenji Kusumoto (K)

Department of Plastic and Reconstructive Surgery, Kansai Medical University, 2-5-1 Shin-machi, Hirakata City, Osaka, 573-1010, Japan.

Classifications MeSH